Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2

(2018) Hua Chen et al.   Molecular Cancer

Upregulation of HES1 Promotes Cell Proliferation and Invasion in Breast Cancer as a Prognosis Marker and Therapy Target via the AKT Pathway and EMT Process

(2018) Xiaoying Li et al.   Journal of Cancer

The emerging roles of the polycistronic miR-106b∼25 cluster in cancer – A comprehensive review

(2018) Dawid Mehlich et al.   BIOMEDICINE & PHARMACOTHERAPY

miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS

(2017) Min-Zu Wu et al.   NATURE CELL BIOLOGY

HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene

(2017) Jasmine Samal et al.   Scientific Reports

The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival

(2016) Ines Vasconcelos et al.   BREAST

microRNAs in the Same Clusters Evolve to Coordinately Regulate Functionally Related Genes

(2016) Yirong Wang et al.   MOLECULAR BIOLOGY AND EVOLUTION

MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia

(2016) Chiranjib Chakraborty et al.   Oncotarget

Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients’ Outcome in Basal-Like Breast Cancer

(2016) Vera Kloten et al.   PLoS One

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

(2015) A. S. Coates et al.   ANNALS OF ONCOLOGY

Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing

(2015) Yao-Yin Chang et al.   Molecular Cancer

Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma

(2015) V. Sandhu et al.   Molecular Oncology

Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer

(2014) Kelly A Avery-Kiejda et al.   BMC CANCER

Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions

(2014) K. W. Witwer   CLINICAL CHEMISTRY

MicroRNA miR-92a-1 biogenesis and mRNA targeting is modulated by a tertiary contact within the miR-17∼92 microRNA cluster

(2014) Steven G. Chaulk et al.   NUCLEIC ACIDS RESEARCH

Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p

(2014) Carlos Marino Cabral Calvano Filho et al.   TUMOR BIOLOGY

Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer

(2014) Jinhua Hu et al.   TUMOR BIOLOGY

The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease

(2013) E Mogilyansky et al.   CELL DEATH AND DIFFERENTIATION

Tackling the Diversity of Triple-Negative Breast Cancer

(2013) N. C. Turner et al.   CLINICAL CANCER RESEARCH

MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes

(2013) F Liu et al.   ONCOGENE

Biogenesis of intronic miRNAs located in clusters by independent transcription and alternative splicing

(2013) P. Ramalingam et al.   RNA

miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer

(2013) YUE-JUN HE et al.   Experimental and Therapeutic Medicine

Intratumoral Heterogeneity of MicroRNA Expression in Breast Cancer

(2012) Mithu Raychaudhuri et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

MicroRNA and cancer

(2012) Martin D. Jansson et al.   Molecular Oncology

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Perk-dependent repression of miR-106b-25 cluster is required for ER stress-induced apoptosis

(2012) S Gupta et al.   Cell Death & Disease

MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing

(2011) T. A. Farazi et al.   CANCER RESEARCH

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

MicroRNAs in body fluids—the mix of hormones and biomarkers

(2011) Maria Angelica Cortez et al.   Nature Reviews Clinical Oncology

Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer

(2011) K Kim et al.   ONCOGENE

Targeting MYC dependence in cancer by inhibiting BET bromodomains

(2011) J. A. Mertz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis

(2011) Steven G Chaulk et al.   RNA Biology

miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1

(2010) Hongling Li et al.   BREAST CANCER RESEARCH AND TREATMENT

The Myc-miR-17 92 Axis Blunts TGF  Signaling and Production of Multiple TGF -Dependent Antiangiogenic Factors

(2010) M. Dews et al.   CANCER RESEARCH

The MicroRNA Spectrum in 12 Body Fluids

(2010) J. A. Weber et al.   CLINICAL CHEMISTRY

Multiple E2F-Induced MicroRNAs Prevent Replicative Stress in Response to Mitogenic Signaling

(2010) M. J. Bueno et al.   MOLECULAR AND CELLULAR BIOLOGY

Negative regulation of the tumor suppressor p53 gene by microRNAs

(2010) M Kumar et al.   ONCOGENE

The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog-Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog-Treated Cerebellar Neural Precursors

(2009) P. A. Northcott et al.   CANCER RESEARCH

miR-19 is a key oncogenic component of mir-17-92

(2009) V. Olive et al.   GENES & DEVELOPMENT

Many roads to maturity: microRNA biogenesis pathways and their regulation

(2009) Julia Winter et al.   NATURE CELL BIOLOGY

Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines

(2009) S-K Leivonen et al.   ONCOGENE

A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response

(2009) Sanjay Chandriani et al.   PLoS One

Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types

(2009) Roy Navon et al.   PLoS One

E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer

(2008) Fabio Petrocca et al.   CANCER CELL

Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters

(2008) Andrea Ventura et al.   CELL

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

(2008) L.-X. Yan et al.   RNA